A NICE step backwards?
This article was originally published in Scrip
Executive Summary
It looks as if NICE is to lose its power to determine which drugs should be funded by the National Health Service in England and Wales. While there is much speculation as to exactly what the government has in mind for the institute, judging by comments from health officials its bark is likely to be worse than its bite come 2014.
You may also be interested in...
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.
UK Explains New Rules On Parallel Imports From EU
Guidance from the Medicines and Healthcare products Regulatory Agency says that the packaging of parallel imported medicines must make clear that they are for the UK market only.